جستجوی استاد راهنمای دانشگاهی

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +۵ مورد دیگر

Professor Victor Fung is a leading academic in neurology and motor control at the Sydney Medical School , University of Sydney. He serves as Director of the Movement Disorders Unit at Westmead Hospital and holds prominent roles in the International Parkinson and Movement Disorder Society (President) and the Asia Pacific Affairs Committee of the Australian and New Zealand Association of Neurologists. His research focuses on Parkinson's disease , dystonia , tremor , and movement disorder genetics , with over 250 peer-reviewed publications and an h-index of 61. His work spans Clinical trials for Parkinson's treatments (e.g., foslevodopa/foscarbidopa infusion, incobotulinumtoxinA) Genetic studies on dystonia and Parkinsonism Neurophysiological assessments of tremor and balance Development of screening tools for dystonia and Parkinson's complications Key article trends highlight genetic diversity in dystonia, neuroinflammatory mechanisms in tremor, and behavioral neurology in Parkinson's disease. He contributes to editorial boards of npj Parkinson's Disease , Journal of Clinical Movement Disorders , and Faculty Opinions . While no explicit student lists are provided, his collaborations span global institutions. His clinical work at Westmead Hospital addresses device-assisted therapies and complex movement disorders.

• Neurology
• Movement Disorders
• Parkinson's Disease
• +۶ مورد دیگر

Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788

• Molecular Immunology
• Cell Signaling
• Signal Transduction Pathways
• +۴ مورد دیگر

Eduardo E. Benarroch, M.D., is a Professor of Neurology and Consultant in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. His research focuses on neurochemical mechanisms underlying neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body diseases, with emphasis on brainstem and hypothalamic neuronal groups controlling homeostasis. His work is supported by the MSA Coalition and has contributed to understanding autonomic, respiratory, and sleep symptom mechanisms in Parkinson's disease. Dr. Benarroch holds a D.Sci. in Physiology from Buenos Aires University and completed multiple fellowships including NIH Fogarty International Fellowship at Cornell University. He has held leadership roles including President of the American Autonomic Society and Co-Director of Mayo's Neuroscience Laboratory. His 286+ publications span neurochemical pathology, autonomic disorders, and clinical neurology. Awarded the AB Baker Lifetime Achievement Award in Neurologic Education, he has received repeated teaching honors including Mayo's Distinguished Educator Award. His professional memberships include American Academy of Neurology, Society for Neuroscience, and Sigma Xi. He has advised numerous trainees and contributed to consensus guidelines on dysphagia in neurodegenerative diseases.

• Neurodegenerative disorders
• Autonomic disorders
• Parkinson's disease
• +۳ مورد دیگر

Dr. Arpan Mehta is an Independent Investigator at the MRC Protein Phosphorylation and Ubiquitylation Unit, specializing in neurodegenerative diseases with a focus on Amyotrophic Lateral Sclerosis (ALS) and frontotemporal dementia. He was awarded the 51st Sir John Halliday Croom Medal and Lectureship by the Royal College of Physicians of Edinburgh for his groundbreaking research on ALS mechanisms. His work explores the role of kinases and genetic mutations (e.g., C9ORF72) in neurodegeneration, alongside mitochondrial dysfunction and clinical trial methodologies. Research interests include molecular mechanisms underlying ALS, neuroimmunology, and improving clinical trial designs for neurodegenerative diseases. Dr. Mehta advocates for rigorous research standards, addressing reproducibility challenges, and optimizing therapeutic approaches. His recent studies investigate mitochondrial bioenergetic deficits in ALS motor neurons and the impact of cerebrospinal fluid (CSF) toxicity. Awards: Sir John Halliday Croom Medal and Lectureship (2025) His publications span clinical neurology, neurodegenerative disease mechanisms, and ethical aspects of medical practice. Dr. Mehta emphasizes interdisciplinary collaboration to advance understanding of ALS pathogenesis and translational therapies.

• Neurodegenerative Diseases
• Amyotrophic Lateral Sclerosis (ALS)
• Molecular Neuroscience
• +۳ مورد دیگر

Stephen A. Boyd is a University Distinguished Professor in the Department of Plant, Soil and Microbial Sciences within Michigan State University's College of Agriculture and Natural Resources. His research spans environmental chemistry and microbiology with a focus on soil systems. His educational background includes a B.S. in Chemistry from Central Michigan University (1975), and M.S. and Ph.D. in Soil Chemistry from Purdue University (1978, 1980). Dr. Boyd's research investigates organic contaminant movement in soil, microbial/catalytic degradation mechanisms, and remediation technologies for contaminated soils/sediments. His work features innovative approaches including chemically modified clays for contaminant sorption and degradation, mechanistic studies of toxicant interactions with natural/modified clays, and development of in-situ soil modification technologies. He extensively examines biodegradation of xenobiotics (particularly PCB reductive dechlorination) and bioavailability of soil-bound contaminants to degrading bacteria. His 15 most recent publications reveal strong trends in clay-based contaminant immobilization, pharmaceutical/water pollutant interactions, dioxin chemistry, and nanomaterial applications for environmental remediation, with dominant fields being environmental chemistry, soil science, and contaminant toxicology. University Distinguished Professor (MSU, 2005) Jackson Award in Soil Science (SSSA, 2004) Highly Cited Researcher (Institute for Scientific Information, 2002) Distinguished Faculty Award (MSU, 2001) Soil Science Research Award (SSSA, 1999) Dr. Boyd has secured significant research funding including a recent $750K USDA grant (2022) for PFAS mitigation research. His laboratory focuses on clay chemistry applications for environmental remediation, with notable breakthroughs in soil cleansing technologies and biochar applications. Current work emphasizes advanced contaminant degradation pathways and practical field applications of his soil modification technologies.

• Environmental Chemistry
• Soil Microbiology
• Contaminant Remediation
• +۵ مورد دیگر

Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.

• Virology
• Molecular Pathology
• Host-Pathogen Interactions
• +۵ مورد دیگر

Ajaz Sheikh, M.D. serves as Associate Professor and Director of the Clinical Neurophysiology Fellowship Program at the University of Toledo College of Medicine, specializing in Epilepsy, Sleep Medicine, and Intraoperative Monitoring. His clinical work integrates advanced neurophysiological diagnostics with comprehensive patient care at the Neuroscience Center. Education: M.B.B.S: University of Kashmir, Government Medical College Srinagar (1998-2004) Internship: University of Toledo (2010-2011) Residency: Psychiatry (University of Kashmir, 2005-2008); Neurology (University of Toledo, 2011-2014) Fellowship: Clinical Neurophysiology/Epilepsy (Case Medical Center, 2014-2015); Sleep Medicine (Duke University, 2015-2016) Dr. Sheikh's research examines seizure triggers, comorbidities in drug-resistant epilepsy, and neurophysiological diagnostic challenges. His work bridges clinical practice with systematic reviews on rare neurological conditions like CLIPPERS and Isaac Syndrome, emphasizing practical applications for improving diagnostic accuracy and treatment protocols in neurocritical care settings. Recent publications (2023-2025) reveal a strong focus on epilepsy comorbidities, with significant contributions to understanding ADHD-epilepsy interactions, geriatric seizure patterns, and autoimmune neurological disorders. His systematic reviews on CLIPPERS and Isaac Syndrome demonstrate methodological rigor while addressing critical gaps in rare disease management. Scientific Awards: Alpha Omega Alpha Induction (2023) A.B. Baker Teaching Recognition Award (2020) Outstanding Neurology Attending Award (2018-2019) Arnold P. Gold Humanism Award (2013, 2014) Outstanding Resident Teaching Award (2014) As Principal Investigator for the ENGAGE-E-001 alprazolam trial and Co-Investigator on four active epilepsy drug studies (natalizumab, padsevonil, XEN1101, SAGE-547), Dr. Sheikh leads translational research targeting super-refractory status epilepticus and drug-resistant focal epilepsy. His prior work in Kashmir included schizophrenia and depression drug trials, reflecting global research engagement. Through the Clinical Neurophysiology Fellowship Program, Dr. Sheikh trains next-generation neurophysiologists while collaborating on multi-center trials that advance evidence-based protocols for complex seizure disorders and intraoperative monitoring standards.

• Sleep Medicine
• Intraoperative Monitoring
• Epilepsy
• +۳ مورد دیگر

Dr. Enrico Opri is an Assistant Professor in the Department of Biomedical Engineering at the University of Michigan , where he directs the Opri Lab. His research focuses on engineering novel methodologies to automate and enhance clinical procedures in neuromodulation for neurological disorders such as Parkinson’s, Tourette syndrome, essential tremor, and epilepsy. Research Focus Neurophysiological activity in basal ganglia-thalamocortical circuits Therapeutic effects of neuromodulation (e.g., Deep Brain Stimulation, cortical stimulation mapping) Identification of neurological biomarkers for improved clinical procedures Advancements in closed-loop neurostimulation systems Article Trends Dr. Opri's recent publications emphasize closed-loop deep brain stimulation (DBS) systems, computational modeling of neural activity, and the identification of biomarkers for neurological disorders. Key subfields include Parkinson’s disease motor dynamics, Tourette syndrome tic detection, essential tremor treatment, and cortico-thalamic coupling mechanisms. His work bridges biomedical engineering and clinical neuroscience, focusing on translating technological innovations into therapeutic applications.

• Neuromodulation
• Deep Brain Stimulation (DBS)
• Neurological Disorders
• +۴ مورد دیگر

Nasrin Asgari is a Clinical Professor at the Faculty of Health Sciences, University of Southern Denmark , and Head of Research at the Neurology Department (Slagelse) within the Department of Regional Health Research, IRS - Næstved, Slagelse, Ringsted Hospitals (NSR). Her work bridges clinical neurology with advanced immunological research, focusing on neuromyelitis optica (NMO) and multiple sclerosis (MS) pathogenesis. Research Interests: Epidemiology and immunology of Aquaporin-4 antibody disorders Myelin Oligodendrocyte Glycoprotein (MOG) antibody-associated diseases Comorbidity analysis in CNS inflammatory conditions Experimental treatments in MS-mouse models Scientific Contributions include groundbreaking studies on NMOSD/MOGAD comorbidities, vascular risk factors in MS therapies, and qualitative investigations into chronic illness well-being. Her recent articles highlight collaborations with international consortia like the Guthy Jackson Charitable Foundation and DMSG study group. Projects encompass the IMAGINE initiative on immune aging in neurological diseases and the Optical Coherence Tomography evaluation of MS progression. She also serves as organizational project manager for movement-based interventions in chronic illness.

• Neuromyelitis Optica
• Multiple Sclerosis
• Neuroimmunology
• +۵ مورد دیگر

Sarosh R. Irani is a Professor of Neurology and Neuroscience at Mayo Clinic, Jacksonville, Florida, and an Adjunct Professor of Neurology at the University of Southern Denmark. He is a leading neurologist and scientist specializing in autoimmune neurological diseases, with a focus on autoimmune encephalitis, neuromyelitis optica, and antibody-mediated disorders. Previously, he served as Professor of Autoimmune Neurology at the University of Oxford. Education: D.Phil. in Clinical Neurology, University of Oxford; B.M., B.Ch. in Medicine, University of Oxford Professional Training: Clinical residency in neurology (UK), Fulbright Fellowship in multiple sclerosis and autoimmune neurology (UCSF, USA) Leadership: Founder of Oxford Autoimmune Neurology Clinic; leads a research group at Mayo Clinic Dr. Irani's research spans both clinical and laboratory domains. His work has been pivotal in identifying and characterizing autoimmune encephalitis subtypes, particularly those associated with LGI1 and CASPR2 antibodies. He has made landmark contributions to understanding B cell dynamics, monoclonal antibody pathogenicity, and immunotherapeutic strategies. His team has published over 200 scientific papers and discovered key biomarkers and clinical phenotypes. Analysis of his recent publications reveals a strong focus on autoimmune encephalitis mechanisms, B cell immunology, patient-reported outcomes, neuroimaging, and translational models. His work integrates genetics, immunology, and clinical neurology to advance diagnostics and therapies. His scientific awards include the Cozzarelli Prize (2024), Clinical Science Prize from the International Society of Neuroimmunology (2021), Graham Bull Prize (2019), and the Wellcome Intermediate Fellowship (2014), among many others. Dr. Irani has supervised over 50 international clinicians and scientists and mentored multiple students and fellows to independent research careers. He is actively involved in clinical trials, patient advocacy (e.g., Encephalitis Society, Autoimmune Encephalitis Alliance), and international collaborations. His lab investigates B cell receptor sequencing, monoclonal antibody cloning, and cross-compartmental immune dynamics in neurological autoimmunity.

• Autoimmune Neurology
• Autoimmune Encephalitis
• Neuromyelitis Optica
• +۹ مورد دیگر

Virginia Gao, M.D., Ph.D., is an Assistant Professor of Neurology and Neuroscience at Weill Cornell Medical College, Cornell University, and a board-certified neurologist specializing in Movement Disorders at NewYork-Presbyterian Hospital. As the Louis and Rachel Rudin Clinical Scholar in Neurology, she directs clinical care at the Parkinson's Disease & Movement Disorders Institute while leading biomarker discovery research and medical education initiatives. Her educational background includes: B.A. in Neuroscience from Columbia University (2008) M.D. and Ph.D. from Mount Sinai School of Medicine (2018) Neurology Residency at Weill Cornell (Chief Resident) Movement Disorders Fellowship at Weill Cornell/Columbia Dr. Gao's research centers on the gut-brain axis in Parkinson's disease, investigating alpha-synuclein pathology in the enteric nervous system as an early biomarker. Her work bridges molecular neuroscience with clinical neurology to develop diagnostic tools and therapeutic targets for neurodegeneration. She directs an NIH-funded clinical trial focused on Parkinson's biomarker discovery. Her 15 most recent publications (2020-2025) reveal a concentrated focus on Parkinson's disease mechanisms, particularly the role of alpha-synuclein in synaptic dysfunction and gut-brain interactions. Key themes include enteric nervous system pathology as a diagnostic window, systemic influences on brain health in aging, and innovative approaches to biomarker validation through multi-omics techniques. Major recognitions include: 2025 Louis and Rachel Rudin Clinical Scholar in Neurology 2023 Emerging Scholar Award (American Neurological Association) 2022 Leon Levy Fellowship in Neuroscience 2021 McGraw Fellowship in Neurology Research 2012 Ruth L. Kirchstein National Research Service Award 2008 Fulbright Scholarship Dr. Gao serves as Co-Director for the Area of Concentration in Neurodegeneration for medical students and Associate Program Director for Research in the Neurology Residency Program. Her research is funded by the National Institutes of Health, Leon Levy Foundation, McGraw Fellowship, American Academy for Neurology, and the Clinical and Translational Science Center (NCATS UL1 grant 2022-2027). She leads the Parkinson's biomarker research team within the Neurology Department's Movement Disorders Institute.

• Movement Disorders
• Parkinson's Disease
• Gut-Brain Axis
• +۳ مورد دیگر

Cesare Gagliardo is a Researcher (MEDS-22/B) at the University of Palermo, Department of Biomedicine, Neuroscience and Advanced Diagnostics, School of Medicine and Surgery. He maintains regular office hours on Wednesdays from 10:00 to 12:00 at the Radiological Sciences Section. His academic responsibilities include teaching diagnostic imaging courses across multiple health professions programs including Nursing, Hearing Prosthetic Techniques, and Neuroscience. Dr. Gagliardo's research focuses on advanced diagnostic imaging techniques, particularly in neuroradiology and MRI-guided focused ultrasound applications. His work spans neurological disorders, peripheral nerve pathologies, and innovative non-invasive surgical approaches. He has made significant contributions to transcranial MRI-guided focused ultrasound surgery, publishing some of the world's first experiences with this technology for treating essential tremor and other neurological conditions. Analysis of his publication record reveals a strong emphasis on translational research connecting imaging technology with clinical applications. His work demonstrates expertise in diffusion kurtosis imaging, resting state fMRI, and the diagnostic applications of ultrasound in peripheral nerve pathologies. The research trajectory shows progression from foundational imaging techniques to innovative therapeutic applications of focused ultrasound. His scientific contributions include pioneering work in transcranial MRI-guided focused ultrasound surgery, with publications documenting the world's first experiences with this technology. His research spans multiple disciplines including neuroscience, radiology, neurosurgery, and gynecology, demonstrating interdisciplinary collaboration across medical specialties. Dr. Gagliardo actively contributes to medical education through multiple courses in diagnostic imaging, neuroradiology, and medical advanced diagnostics across various health profession programs at the University of Palermo. His teaching spans undergraduate and graduate level instruction for nursing, neuroscience, and specialized health professions.

• Diagnostic Imaging
• Neuroradiology
• Neuroscience
• +۴ مورد دیگر

Vladimir Coric, MD, is an Associate Clinical Professor of Psychiatry at Yale School of Medicine and Chief Executive Officer of Biohaven Pharmaceutical Holding Company. He specializes in neurodegenerative diseases, clinical trials, and drug development, with a focus on Parkinson’s, Alzheimer’s, and ataxia. His research involves developing composite scales for disease progression assessment and evaluating therapies like troriluzole and taldefgrobep alfa. Education: MD from Wake Forest University (1996), Yale Psychiatry Residency (2000), and Chief Resident at the National Center for PTSD (2000). Awards include the 2018 Ernst & Young Entrepreneur of the Year (New York region). He has authored over 90 publications, emphasizing neurology, clinical pharmacology, and translational medicine. Key roles: Leader in Biohaven’s clinical-stage biopharmaceutical efforts targeting neurological disorders. His work bridges academia and industry, focusing on unmet medical needs in neurology. Collaborations include studies on biomarkers, disease progression metrics, and novel drug candidates.

• Neurology
• Neurodegenerative Diseases
• Clinical Trials
• +۵ مورد دیگر

Prof. Dr. Aynur KIRBAŞ is a distinguished Professor of Medical Biochemistry at Ahi Evran University, Faculty of Medicine, where she has served since 2023. Previously, she was an Associate Professor at Kırşehir Ahi Evran University (2022-2023) and Recep Tayyip Erdoğan University (2013-2022), and an Assistant Professor at Recep Tayyip Erdoğan University (2009-2013). She currently serves as both Professor and Head of Department at Ahi Evran University, and as Education Coordinator since 2025. Dr. KIRBAŞ earned her Bachelor's Degree from Atatürk University, Faculty of Medicine (1994-2000) and completed her PhD/Medical Specialization at Süleyman Demirel University, Faculty of Medicine Hospital Application and Research Center (2002-2007). She has obtained proficiency in English with a score of 77 on the ÜDS exam in Fall 2010. Her research focuses on medical biochemistry, particularly oxidative stress, inflammation markers, and biomarker research in various clinical conditions. With 102 publications to her name including 84 articles, she has made significant contributions to understanding biochemical markers in neurological disorders, cardiovascular disease, metabolic conditions, and inflammatory processes. Her work frequently examines YKL-40, copeptin, and other novel biomarkers across diverse clinical settings from stroke to rheumatological conditions. Dr. KIRBAŞ has led or participated in 17 research projects, primarily funded by higher education institutions, investigating topics ranging from hirudotherapy effects to novel inflammatory markers in pleural effusion. Her most recent projects examine the effects of hirudotherapy on exercise-induced fatigue and the relationship between serum BDNF and NGF levels in restless leg syndrome. She has received recognition for her work, including an award in 2006 for research on lisinopril's effects on lipid peroxidation in hypertensive rats. Her scholarly impact is evident with 675 citations and an h-index of 16 according to UNIS metrics. Dr. KIRBAŞ actively contributes to her field through editorial work for journals including Current Research in Health Sciences and The Eurasian Journal of Medicine, and maintains professional memberships in the Turkish Clinical Biochemistry Association, Turkish Biochemistry Association, and Clinical Biochemistry Specialists Association. Her teaching portfolio includes numerous biochemistry courses covering topics from vitamin metabolism to laboratory quality control.

• Medical Biochemistry
• Clinical Biochemistry
• Oxidative Stress
• +۵ مورد دیگر